1,5-DIAMINO-2-(4-((4-(DIBUTYLAMINO)-6-FLUORO-1,3,5-TRIAZIN-2-YL)OXY)PHENYL)-4,8-DIHYDROXYANTHRAQUINONE
UNII S9924SQ424
Substance Identification & Data
This profile provides standardized clinical and technical data for 1,5-diamino-2-(4-((4-(dibutylamino)-6-fluoro-1,3,5-triazin-2-yl)oxy)phenyl)-4,8-dihydroxyanthraquinone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S9924SQ424.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 94160-37-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H31FN6O5 QHZWNQUCVXXIES-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1,5-diamino-2-(4-((4-(dibutylamino)-6-fluoro-1,3,5-triazin-2-yl)oxy)phenyl)-4,8-dihydroxyanthraquinone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.